Background Peripheral blood skin-homing/cutaneous lymphocyte antigen (CLA)+ T cells
emerge as biomarkers of cutaneous immune activation in patients with inflammatory skin …

Vitiligo is an acquired depigmentation skin disease caused by immune-mediated death of
melanocytes. The most common treatment for vitiligo is narrow band ultraviolet B …

The pathophysiology of vitiligo is complex although recent research has discovered several
markers which are linked to vitiligo and associated with disease activity. Besides providing …

Introduction: Dysregulation of melanocyte function is associated with vitiligo, an idiopathic
autoimmune hypopigmentary skin disorder, caused by the selective destruction of …

Accumulating studies have indicated immune-based destruction of melanocytes in both
segmental vitiligo (SV) and non-SV (NSV). Whereas SV often occurs unilaterally during …

Several theories have been proposed to explain disease pathogenesis, considering the
roles of increased inflammatory and cytotoxic immune responses, neuropeptides …

Vitiligo is an acquired immune-mediated disorder of pigmentation clinically characterized by
well-defined depigmented or chalk-white macules and patches on the skin. The prevalence …

Vitiligo is a skin disorder with melanocyte destruction and an autoimmune basis. Given the
importance of cytokines in autoimmunity, we aimed to find the cytokine profile of innate and …

Vitiligo is the most common depigmenting disorder, affecting 0.5% of the population. This
stigmatizing disease has a major social impact with high unmet needs, and no real curative …

Background Vitiligo is an autoimmune disease associated with alteration in levels of various
cytokines. However, there are very few studies in this regard. Objectives To assess the …